Di You (迪友)迪友
This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。
Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。
生产企业Manufacturer
- 沈阳兴齐眼药股份有限公司Chinese legal name: 沈阳兴齐眼药股份有限公司
主要成分Active Ingredients
- 加替沙星Jiati Shaxing
药物知识说明
加替沙星是一种在国家药监局注册认定的药品。该药品含有加替沙星-d96279c2等成分。
该药品关联的活性成分包括：加替沙星Jiati Shaxing。这些成分信息来自国家药监局数据库。
该药品标注的生产企业为：沈阳兴齐眼药股份有限公司Chinese legal name: 沈阳兴齐眼药股份有限公司。
您可以探索含有相同成分的其他药品：加替沙星-d96279c2成分药品。
本页面内容来自国家药监局数据库，MedicineGraph在此基础上提供关系图谱和知识导航。
Medicine Knowledge
This medicine (original name: 迪友) is a medicine registered with the national drug regulatory authority. It contains recorded ingredients as active ingredient(s).
Active ingredients associated with this product: 加替沙星Jiati Shaxing.
Manufacturers recorded for this product: 沈阳兴齐眼药股份有限公司Chinese legal name: 沈阳兴齐眼药股份有限公司.
Explore other medicines containing the same ingredient: 加替沙星 productsProducts containing this recorded ingredient.
Source: MedicineGraph authoritative database. Relationships derived from registered product information.
这是什么What is this
- 通用名/品名Recorded product name: 迪友Recorded Chinese name: 迪友
- 规格Specification: 药用软膏铝管，0.3%，5g/支。Recorded Chinese description: 药用软膏铝管，0.3%，5g/支。
本段仅展示注册/说明书已记录的身份属性，不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.
主要成分Ingredients
生产企业Manufacturer
- 沈阳兴齐眼药股份有限公司Chinese legal name: 沈阳兴齐眼药股份有限公司
注册信息NMPA approval number
- 批准文号NMPA approval number: 国药准字H20090161
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.
- 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
- 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.
本段为已核准说明书原文摘录（非改写、非AI摘要），非正式英文标签，亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.
English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.
NMPA approval number
国药准字H20090161
Manufacturer
Chinese legal name: 沈阳兴齐眼药股份有限公司 (domestically manufactured)
Indications
English translation unavailable. The original Chinese source label remains available below.
Dosage and administration
English translation unavailable. The original Chinese source label remains available below.
Adverse reactions
English translation unavailable. The original Chinese source label remains available below.
Contraindications
English translation unavailable. The original Chinese source label remains available below.
Precautions
English translation unavailable. The original Chinese source label remains available below.
Storage
English translation unavailable. The original Chinese source label remains available below.
Specification
English translation unavailable. The original Chinese source label remains available below.
中文说明书原文Original Chinese source label
批准文号
国药准字H20090161
生产企业
沈阳兴齐眼药股份有限公司(国产)
适应症
本品适用于敏感菌所引起的急性细菌性结膜炎。
用法用量
每次1滴，每天3次。
不良反应
眼部用药常见的不良反应为结膜刺激、流泪、角膜炎和乳头状结膜炎，发生率约为5-10%。发生率在1-4%的不良反应为球结膜水肿、结膜充血、眼干、流泪、眼部刺激、眼部疼痛、眼睑水肿、头痛、红眼、视力减退和味觉混乱。
禁忌
本品禁用于对加替沙星或喹诺酮类药物过敏者。糖尿病患者谨遵医嘱、慎用。
注意事项
1. 本品只限于滴眼用，不能结膜下注射使用，也不能直接注入眼前节。2. 包括加替沙星是在内的喹诺酮类药物全身给药（如口服和静脉给药）偶尔可出现严重的不良反应，有些患者在第一次用药后出现。一些反应伴随着心衰、意识丧失、血管性水肿（包括喉头、咽、面部水肿）?气管梗阻、呼吸困难、荨麻疹、瘙痒。出现过敏症状，立即停药。3. 避免使用接触镜，避免眼睛、手指和其他物品污染容器瓶口。4. 像其他抗生素一样，长期应用可能导致非敏感菌如真菌的过度生长，如出现二重感染应停止使用本品，改变治疗。5. 本品开启后最多可使用四周。
贮藏
密闭常温保存
规格
药用软膏铝管，0.3%，5g/支。
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据。National Medical Products Administration (China) medicine-registration data.
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.